Incannex Healthcare (IXHL) Non-Current Assets (2022 - 2026)

Incannex Healthcare (IXHL) posted quarterly Non-Current Assets of $188000.0 for Q1 2026, down 66.9% year-on-year from $568000.0 in Q1 2025, and down 42.68% on a QoQ basis from $328000.0 in Q4 2025.

Incannex Healthcare (IXHL) Non-Current Assets (2022 - 2026) Analysis & Trends

Incannex Healthcare (IXHL) has reported Non-Current Assets for 5 consecutive years, with $188000.0 the latest figure, recorded in Q1 2026.

  • Quarterly Non-Current Assets fell 66.9% year-over-year to $188000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 million (down 50.04% YoY) and the FY2025 annual result came in at $485000.0, down 42.6% from the prior year.
  • Non-Current Assets retreated to $188000.0 in Q1 2026 per IXHL's latest filing, from $328000.0 in the prior quarter.
  • Over the last five years, Non-Current Assets for IXHL reached as high as $53.1 million in Q4 2022 and fell as low as $188000.0 in Q1 2026.
  • A 5-year average of $5.0 million and a median of $694000.0 in 2023 frame the typical range for Non-Current Assets.
  • Annual changes were most pronounced in 2023 — Non-Current Assets sank 98.07% — and 2024, when it rose 7.51%.
  • Year by year, Non-Current Assets stood at $53.1 million in 2022, then plunged by 98.07% to $1.0 million in 2023, then sank by 41.38% to $602000.0 in 2024, then slumped by 45.51% to $328000.0 in 2025, then sank by 42.68% to $188000.0 in 2026.
  • According to Business Quant data, Non-Current Assets over the past three periods registered $188000.0, $328000.0, and $425000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 36.78 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 26.33 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 8.68 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 79.20 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 3.84 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 15.70 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 25.92 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 2.47 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 9.64 Bn
10 Incannex Healthcare 3.63 Mn 3.63 Mn - 188,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 188,000.00
Dec 31, 2025 328,000.00
Sep 30, 2025 425,000.00
Jun 30, 2025 485,000.00
Mar 31, 2025 568,000.00
Dec 31, 2024 602,000.00
Sep 30, 2024 839,000.00
Jun 30, 2024 845,000.00
Mar 31, 2024 931,000.00
Dec 31, 2023 1.03 Mn
Jun 30, 2023 786,000.00
Dec 31, 2022 53.09 Mn